Function and development of a C. elegans GABAergic interneuron

$340,071R01FY2014NSNIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications & trials

Paper 39475047 Paper 39422452 Paper 39132051 Paper 39103170 Paper 39071424 Paper 38915494 Paper 38895397 Paper 38304163 Paper 36595352 Paper 36178933 Paper 35324425 Paper 30150774 Paper 29429615 Paper 29301976 Paper 27740909 Paper 26341465 Paper 26291158 Paper 26153233 Paper 26096732 Paper 26083757 Paper 26073017 Paper 25913400 Paper 24929660 Paper 24558259 Paper 24510690 Paper 24361693 Paper 24353061 Paper 24243022 Paper 24081909 Paper 23801671 Paper 23788625 Paper 23457234 Paper 23201143 Paper 23103163 Paper 23051646 Paper 22119902 Paper 21985672 Paper 21737278 Paper 21692658 Paper 21555395 Paper 21148348 Paper 20923973 Paper 20891032 Paper 20663572 Paper 20537527 Paper 20439776 Paper 20431118 Paper 20040592 Paper 19641012 Paper 19620971 Paper 19550137 Paper 19523832 Paper 19386265 Paper 19287374 Paper 19189954 Paper 19107202 Paper 19104055 Paper 19062279 Paper 19060335 Paper 18758453 Paper 18677319 Paper 18463285 Paper 18165801 Paper 18050449 Paper 17717195 Paper 17606643 Paper 17381295 Paper 17141609 Paper 16921378 Paper 16547101 Paper 16335715 Paper 16291785 Paper 16051801 Paper 15082545 Paper 12906792

Abstract

DESCRIPTION (provided by applicant): GABAergic neurons are a prominent class of neurons whose dysfunction can results in various disease states. The developmental mechanisms that result in terminal differentiation of GABAergic neurons and the functional properties of many GABAergic neurons are incompletely understood. We propose here to use the experimental advantages of the nematode C.elegans to decipher the gene regulatory events - both on the level of cis-regulatory elements and trans-acting factors - that induce the expression of terminal identity markers of a single GABAergic interneuron (Aim #1) and we propose to study a potential role of this GABAergic interneuron in controlling metabolic states and life span of C. elegans (Aim #2).

View original record on NIH RePORTER →